Market Highlights:


India Diabetes Market Growth was about US$ 4.77 billion in 2016 and is expected to reach US$ 7.44 billion at a CAGR of 6.5%.

The Diabetes Market in India is well-established & growing pervasively with the rapid pace. Growing prevalence of diabetes fuelled by the changing lifestyle, inclination towards the sedentary lifestyle & growing obesity disorder among people, are some of the predominant driving force contributing to the market growth. Introduction of the novel medicines & therapies, giving the best outcomes is providing impetus to the market growth.  This, in turn, is supporting the market growth of Diabetes in India. Evidently, technological advancements transpired into the field of medical science is also predominant factor propelling the market growth, escalating it pervasively. Seminal efforts & investments put in the development of innovative drugs & therapies, by the key market players to control diabetes are paying off well driving the market growth. Initiatives taken by the Government are playing a major role in fostering the market growth.

On the other hand, factors such as low awareness among people about diabetes treatment, the high manufacturing cost of diabetes management devices along with the skepticism of physicians towards the advancement & efficacies of these devices are likely to impede the growth of diabetes boots. However, the demand for sophisticated devices by the physicians and patients, in turn, is contributing to the market growth to a great extent.

 

India Diabetes Market Players:


There are plenty of large and small market players which operate in this market : Novo Nordisk A/S (Denmark), USV Private Limited (India), sanofi-aventis U.S. LLC (US), Novartis AG (Switzerland), Merck & Co., Inc. (US), Becton Dickinson and Company (US), Roche Diabetes Care, Inc.(US),Johnson & Johnson Services, Inc.(us), Bayer AG (Germany), Ypsomed (Switzerland)

Regional Analysis:

Considering the India scenario of the market, western region is believed to be the largest market for diabetes. Moreover the Eastern and Northern region are also growing and second largest market for India Diabetes. On the other hand, Southern Indian market is expected to grow at significant rate in the India diabetes during the forecasted period. Central region is likely to have a limited but moderate growth in the market.


Market Segmentation:

The Diabetes Market of India can be segmented into 5 key dynamics for the convenience of the report and enhanced understanding.

By Types:  Comprises Type 1, Type 2, and Gestational diabetes.

By Tests:  Fasting Blood Sugar Test, Random Blood Sugar Test, Oral Glucose Tolerance Test, and Initial Glucose Challenge Test among others

By Treatments:  Insulin Therapy, Medications, Transplantation, and Bariatric Surgery among others.

By Devices:  Diabetes Management Devices, & Blood Glucose Monitoring Devices, among others

By Regions:  East, West, North & South Regions of India.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com